These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9479568)

  • 61. Haemophagocytic lymphohistiocytosis in X-linked severe combined immunodeficiency.
    Grunebaum E; Zhang J; Dadi H; Roifman CM
    Br J Haematol; 2000 Mar; 108(4):834-7. PubMed ID: 10792291
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interleukin-2 (IL-2) receptor gamma chain mutations in X-linked severe combined immunodeficiency disease result in the loss of high-affinity IL-2 receptor binding.
    DiSanto JP; Dautry-Varsat A; Certain S; Fischer A; de Saint Basile G
    Eur J Immunol; 1994 Feb; 24(2):475-9. PubMed ID: 8299698
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dysfunctional cytokine receptor signaling in severe combined immunodeficiency.
    Leonard WJ
    J Investig Med; 1996 Aug; 44(6):304-11. PubMed ID: 8795294
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Common cytokine receptor gamma chain (gamma c)-dependent cytokines: understanding in vivo functions by gene targeting.
    Di Santo JP; Kühn R; Müller W
    Immunol Rev; 1995 Dec; 148():19-34. PubMed ID: 8825280
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Successful gene therapy for severe combined immunodeficiency.
    Rosen FS
    N Engl J Med; 2002 Apr; 346(16):1241-3. PubMed ID: 11961154
    [No Abstract]   [Full Text] [Related]  

  • 66. X-linked severe combined immunodeficiency disease and the gamma c receptor component: prospects for molecular diagnosis.
    Farner NL; Voss SD; Sondel PM
    Clin Diagn Lab Immunol; 1995 Sep; 2(5):518-23. PubMed ID: 8548528
    [No Abstract]   [Full Text] [Related]  

  • 67. 'Bubble boy' paradox resolved.
    Nowak R
    Science; 1993 Dec; 262(5141):1818. PubMed ID: 8266068
    [No Abstract]   [Full Text] [Related]  

  • 68. The γ
    Spolski R; Gromer D; Leonard WJ
    F1000Res; 2017; 6():1872. PubMed ID: 29123649
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Outpatient bone marrow transplantation for severe combined immunodeficiency.
    Sorensen RU; Strandjord SE; Coccia PF
    Lancet; 1993 Jan; 341(8836):52. PubMed ID: 8093296
    [No Abstract]   [Full Text] [Related]  

  • 70. Canine Papillomavirus 2 E6 Does Not Interfere With UVB-Induced Upregulation of p53 and p53-Regulated Genes.
    Quinlan S; May S; Weeks R; Yuan H; Luff J
    Front Vet Sci; 2021; 8():570982. PubMed ID: 33748203
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of Genetically Engineered Immunodeficient Animal Models for Nonclinical Testing of Stem Cell Therapies.
    Kim YY; Kim JS; Che JH; Ku SY; Kang BC; Yun JW
    Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33498509
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Abrogation of Constitutive and Induced Type I and Type III Interferons and Interferon-Stimulated Genes in Keratinocytes by Canine Papillomavirus 2 E6 and E7.
    Quinlan S; May S; Weeks R; Yuan H; Luff JA
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32585804
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Generation of knockout rabbits with X-linked severe combined immunodeficiency (X-SCID) using CRISPR/Cas9.
    Hashikawa Y; Hayashi R; Tajima M; Okubo T; Azuma S; Kuwamura M; Takai N; Osada Y; Kunihiro Y; Mashimo T; Nishida K
    Sci Rep; 2020 Jun; 10(1):9957. PubMed ID: 32561775
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In-Vivo Gene Therapy with Foamy Virus Vectors.
    Rajawat YS; Humbert O; Kiem HP
    Viruses; 2019 Nov; 11(12):. PubMed ID: 31771194
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Contemporary Animal Models For Human Gene Therapy Applications.
    Gopinath C; Nathar TJ; Ghosh A; Hickstein DD; Nelson EJR
    Curr Gene Ther; 2015; 15(6):531-40. PubMed ID: 26415576
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gene therapy studies in a canine model of X-linked severe combined immunodeficiency.
    Felsburg PJ; De Ravin SS; Malech HL; Sorrentino BP; Burtner C; Kiem HP
    Hum Gene Ther Clin Dev; 2015 Mar; 26(1):50-6. PubMed ID: 25603151
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Keratinocyte antiviral response to Poly(dA:dT) stimulation and papillomavirus infection in a canine model of X-linked severe combined immunodeficiency.
    Luff JA; Yuan H; Kennedy D; Schlegel R; Felsburg P; Moore PF
    PLoS One; 2014; 9(7):e102033. PubMed ID: 25025687
    [TBL] [Abstract][Full Text] [Related]  

  • 78. IL-12 based gene therapy in veterinary medicine.
    Pavlin D; Cemazar M; Sersa G; Tozon N
    J Transl Med; 2012 Nov; 10():234. PubMed ID: 23171444
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ex vivo γ-retroviral gene therapy of dogs with X-linked severe combined immunodeficiency and the development of a thymic T cell lymphoma.
    Kennedy DR; Hartnett BJ; Kennedy JS; Vernau W; Moore PF; O'Malley T; Burkly LC; Henthorn PS; Felsburg PJ
    Vet Immunol Immunopathol; 2011 Jul; 142(1-2):36-48. PubMed ID: 21536334
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of ex vivo culture of CD34+ bone marrow cells on immune reconstitution of XSCID dogs following allogeneic bone marrow transplantation.
    Kennedy DR; McLellan K; Moore PF; Henthorn PS; Felsburg PJ
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):662-70. PubMed ID: 19450750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.